Bottom line
EIHSX vs SWHFX: the short answer
EIHSX (Eaton Vance Worldwide Health Sciences Fund) and SWHFX (Schwab Health Care Fund) are both mutual funds.
SWHFX is cheaper at 0.8% vs 0.93% — a difference of $13 a year per $10,000 invested.
Over five years, EIHSX returned +6.7% a year vs +6.5% for SWHFX (reporting dates differ).
Updated Nov 19, 2026
EIHSX vs SWHFX side by side
| EIHSX | SWHFX | |
|---|---|---|
| Type | Mutual fund | Mutual fund |
| Fund family | Morgan Stanley | Schwab |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 0.93% | 0.8% |
| Annual cost per $10k | $93 | $80 |
| 10-yr cost on $10k (prospectus) | $1,175 | $990 |
| Max front load | 0% | — |
| 12b-1 fee | 0% | 0% |
| 1-yr return | +3.7% | +15.9% |
| 5-yr return (annualized) | +6.7% | +6.5% |
| 10-yr return (annualized) | +7.2% | +8.1% |
| Best quarter | — | +15.3% |
| Worst quarter | — | −12.1% |
| Net assets (fund) | $757.9M | $642.3M |
| Number of holdings | 42 | 80 |
| Portfolio turnover | 3% | 41% |
| Returns as of | Dec 31, 2024 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
16 of EIHSX's top 25 holdings also appear in SWHFX's top 25.
| Holding | EIHSX | SWHFX |
|---|---|---|
| Eli Lilly & Co | 12.47% | 13.92% |
| AbbVie Inc | 6.46% | 5.81% |
| Johnson & Johnson | 6.45% | 6.94% |
| UnitedHealth Group Inc | 5.49% | 4.74% |
| Roche Holding AG | 5.44% | 2.29% |
| Merck & Co Inc | 5.08% | 4.98% |
| Bristol-Myers Squibb Co | 4.25% | 2.44% |
| Vertex Pharmaceuticals Inc | 3.38% | 1.89% |
| Gilead Sciences Inc | 3.34% | 3.24% |
| Sanofi SA | 2.95% | 1.31% |
| Thermo Fisher Scientific Inc | 2.79% | 2.16% |
| Stryker Corp | 2.21% | 2.11% |
| Boston Scientific Corp | 2.18% | 1.60% |
| Medtronic PLC | 1.80% | 2.29% |
| Abbott Laboratories | 1.65% | 1.60% |
Source: SEC Form N-PORT
EIHSX top 10
- Eli Lilly & Co — 12.47%
- AbbVie Inc — 6.46%
- Johnson & Johnson — 6.45%
- AstraZeneca PLC — 6.24%
- UnitedHealth Group Inc — 5.49%
- Roche Holding AG — 5.44%
- Merck & Co Inc — 5.08%
- Bristol-Myers Squibb Co — 4.25%
- Vertex Pharmaceuticals Inc — 3.38%
- Gilead Sciences Inc — 3.34%
SWHFX top 10
- Eli Lilly & Co — 13.92%
- Johnson & Johnson — 6.94%
- AbbVie Inc — 5.81%
- Merck & Co Inc — 4.98%
- UnitedHealth Group Inc — 4.74%
- Gilead Sciences Inc — 3.24%
- Novartis AG — 2.92%
- Amgen Inc — 2.58%
- Bristol-Myers Squibb Co — 2.44%
- Medtronic PLC — 2.29%
FAQ
What is the difference between EIHSX and SWHFX?
EIHSX (Eaton Vance Worldwide Health Sciences Fund) and SWHFX (Schwab Health Care Fund) are both mutual funds. SWHFX is cheaper at 0.8% vs 0.93% — a difference of $13 a year per $10,000 invested.
Which is cheaper, EIHSX or SWHFX?
SWHFX has the lower expense ratio (0.8%).
Should I own both EIHSX and SWHFX?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.